» Articles » PMID: 33907316

Polygenic Risk Score Analysis for Amyotrophic Lateral Sclerosis Leveraging Cognitive Performance, Educational Attainment and Schizophrenia

Abstract

Amyotrophic Lateral Sclerosis (ALS) is recognised to be a complex neurodegenerative disease involving both genetic and non-genetic risk factors. The underlying causes and risk factors for the majority of cases remain unknown; however, ever-larger genetic data studies and methodologies promise an enhanced understanding. Recent analyses using published summary statistics from the largest ALS genome-wide association study (GWAS) (20,806 ALS cases and 59,804 healthy controls) identified that schizophrenia (SCZ), cognitive performance (CP) and educational attainment (EA) related traits were genetically correlated with ALS. To provide additional evidence for these correlations, we built single and multi-trait genetic predictors using GWAS summary statistics for ALS and these traits, (SCZ, CP, EA) in an independent Australian cohort (846 ALS cases and 665 healthy controls). We compared methods for generating the risk predictors and found that the combination of traits improved the prediction (Nagelkerke-R) of the case-control logistic regression. The combination of ALS, SCZ, CP, and EA, using the SBayesR predictor method gave the highest prediction (Nagelkerke-R) of 0.027 (P value = 4.6 × 10), with the odds-ratio for estimated disease risk between the highest and lowest deciles of individuals being 3.15 (95% CI 1.96-5.05). These results support the genetic correlation between ALS, SCZ, CP and EA providing a better understanding of the complexity of ALS.

Citing Articles

Genetic testing for monogenic forms of motor neuron disease/amyotrophic lateral sclerosis in unaffected family members.

Howard J, Chaouch A, Douglas A, MacLeod R, Roggenbuck J, McNeill A Eur J Hum Genet. 2024; 33(1):7-13.

PMID: 39501102 PMC: 11711763. DOI: 10.1038/s41431-024-01718-4.


Recurrent stroke prediction by applying a stroke polygenic risk score in the Japanese population.

Kojima N, Koido M, He Y, Shimmori Y, Hachiya T, Japan B medRxiv. 2024; .

PMID: 39371120 PMC: 11451717. DOI: 10.1101/2024.06.17.24309034.


Improving prediction models of amyotrophic lateral sclerosis (ALS) using polygenic, pre-existing conditions, and survey-based risk scores in the UK Biobank.

Jin W, Boss J, Bakulski K, Goutman S, Feldman E, Fritsche L J Neurol. 2024; 271(10):6923-6934.

PMID: 39249108 DOI: 10.1007/s00415-024-12644-2.


Screening embryos for polygenic disease risk: a review of epidemiological, clinical, and ethical considerations.

Capalbo A, de Wert G, Mertes H, Klausner L, Coonen E, Spinella F Hum Reprod Update. 2024; 30(5):529-557.

PMID: 38805697 PMC: 11369226. DOI: 10.1093/humupd/dmae012.


Improving prediction models of amyotrophic lateral sclerosis (ALS) using polygenic, pre-existing conditions, and survey-based risk scores in the UK Biobank.

Jin W, Boss J, Bakulski K, Goutman S, Feldman E, Fritsche L medRxiv. 2024; .

PMID: 38585910 PMC: 10996827. DOI: 10.1101/2024.03.28.24305037.


References
1.
Brown R, Al-Chalabi A . Amyotrophic Lateral Sclerosis. N Engl J Med. 2017; 377(2):162-172. DOI: 10.1056/NEJMra1603471. View

2.
Taylor J, Brown Jr R, Cleveland D . Decoding ALS: from genes to mechanism. Nature. 2016; 539(7628):197-206. PMC: 5585017. DOI: 10.1038/nature20413. View

3.
Longinetti E, Mariosa D, Larsson H, Almqvist C, Lichtenstein P, Ye W . Physical and cognitive fitness in young adulthood and risk of amyotrophic lateral sclerosis at an early age. Eur J Neurol. 2016; 24(1):137-142. DOI: 10.1111/ene.13165. View

4.
Rippon G, Scarmeas N, Gordon P, Murphy P, Albert S, Mitsumoto H . An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol. 2006; 63(3):345-52. DOI: 10.1001/archneur.63.3.345. View

5.
Irwin D, Lippa C, Swearer J . Cognition and amyotrophic lateral sclerosis (ALS). Am J Alzheimers Dis Other Demen. 2007; 22(4):300-12. PMC: 10846138. DOI: 10.1177/1533317507301613. View